Results 141 to 150 of about 8,708 (251)

Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15) [PDF]

, 2017
Bassetti, Matteo, Castanheira, Mariana, Duncan, Leonard R., Pfaller, Michael A.   +3 more
core   +1 more source

Ceftolozane/tazobactam disrupts Pseudomonas aeruginosa biofilms under static and dynamic conditions

Journal of Antimicrobial Chemotherapy
Background Pseudomonas aeruginosa biofilms limit the efficacy of currently available antibacterial therapies and pose significant clinical challenges.
Xenia Kostoulias, Ying Fu, Faye C. Morris, Crystal Yu, Yue Qu, Christina C. Chang, Luke V. Blakeway, Cornelia B. Landersdorfer, I. Abbott, Lynn Wang, J. Wisniewski, Yun-song Yu, Jian Li, Anton Y Peleg   +13 more
semanticscholar   +1 more source

Ceftolozane [PDF]

, 2020
openaire   +1 more source

Activity of ceftolozane/tazobactam and imipenem/relebactam against Gram-negative clinical isolates collected in Mexico—SMART 2017–2021

JAC-Antimicrobial Resistance
Objectives To investigate the activities of ceftolozane/tazobactam and imipenem/relebactam against Escherichia coli, Klebsiella pneumoniae and Pseudomonas aeruginosa isolated from hospitalized patients in Mexico in 2017–2021. Methods MICs were determined
J. Karlowsky, S. Lob, F. Siddiqui, T. Polis, J. L. Vallejo, K. Young, M. Motyl, Daniel F. Sahm   +7 more
semanticscholar   +1 more source

PK/PD Target Attainment With Ceftolozane/Tazobactam Using Monte Carlo Simulation in Patients With Various Degrees of Renal Function, Including Augmented Renal Clearance and End-Stage Renal Disease [PDF]

, 2016
Alan J. Xiao, Jennifer A. Huntington, Luzelena Caro, Myra W. Popejoy, Ravina Kullar   +4 more
core   +1 more source

Ceftolozane/tazobactam: a novel antipseudomonal cephalosporin and β-lactamase-inhibitor combination

Infection and Drug Resistance, 2013
Mai-Chi Hong1, Donald I Hsu1,2, Mark Bounthavong3,41Department of Pharmacy Practice and Administration, Western University of Health Sciences, Pomona, 2Department of Pharmacy, St Joseph Hospital, Orange, 3Department of Pharmacy, Veterans Affairs San ...
Hong MC, Hsu DI, Bounthavong M
doaj  

What every intensivist should know about the management of peritonitis in the intensive care unit [PDF]

, 2018
De Waele, Jan
core   +2 more sources

Reply: NDM-producing Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Korea: A Growing Threat Requiring National Attention. [PDF]

Infect Chemother
Kim T, Chong YP.
europepmc   +1 more source

UK Antimicrobial Registry: Virtual Registry-an innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in Scotland. [PDF]

JAC Antimicrob Resist
Goswami C, Turgal E, Mueller T, Bennie M, Parr R, Jones GT, Seaton RA, Jenkins D, Baltas I, Sneddon J, Sandoe JAT, Garraghan F, Brown NM, Macfarlane GJ, Kurdi A.   +14 more
europepmc   +1 more source

Resistance, Ineffectiveness, and Off-Label Use Related to Cephalosporins from the Reserve Group-A Pharmacovigilance Signal Detection Study on EudraVigilance Database. [PDF]

Pharmaceuticals (Basel)
Arseniu AM, Vintila BI, Butuca A, Stoicescu L, Frum A, Chis AA, Arseniu R, Gligor FG, Ghibu S, Morgovan C, Dobrea CM.   +10 more
europepmc   +1 more source